Boston Scientific said that while tariffs pose “unfortunate” headwinds—which are poised to add about $200 million to the cost ...

Boston Scientific stock is up as company officials predict that the ongoing trade war won't hinder double-digit sales growth ...

Baird analyst David Rescott maintained Boston Scientific with an Outperform rating and raised the price target from $115 to $120. Evercore ISI Group analyst Vijay Kumar maintained the stock with an ...

Truist analyst Richard Newitter raised the firm’s price target on Boston Scientific (BSX) to $117 from $113 and keeps a Buy rating on the ...

Baird raised the firm’s price target on Boston Scientific (BSX) to $120 from $115 and keeps an Outperform rating on the shares. The firm ...

Shares of Boston Scientific rose sharply Wednesday after the firm posted better-than-expected quarterly results.

In recent days, Boston Scientific announced a forthcoming CFO change, a Cambridge biotech undertook a 1-for-20 reverse stock ...

Anumana announced that it brought its diagnostic ECG-AI technology into perioperative and acute cardiac care with Boston ...

Boston Scientific (BSX) closed the most recent trading day at $95.12, moving -0.14% from the previous trading session. The stock's change was less than the S&P 500's daily gain of 0.13%.

Boston Scientific BSX shares rallied 6.8% in the last trading session to close at $96.77. This move can be attributable to notable volume with a higher number of shares being traded than in a ...